What is the place of sclerostin in chronic kidney disease, atherosclerosis, and ageing?

被引：0
|
作者：
Andreja Figurek
Goce Spasovski
机构：
[1] University of Zurich,Institute of Anatomy
[2] University of Skopje,University Department of Nephrology, Medical Faculty
来源：
International Urology and Nephrology | 2019年 / 51卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：897 / 898
页数：1
相关论文
共 50 条
  • [1] What is the place of sclerostin in chronic kidney disease, atherosclerosis, and ageing?
    Figurek, Andreja
    Spasovski, Goce
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (05) : 897 - 898
  • [2] Sclerostin and chronic kidney disease
    Mierzwinska, Emilia
    Hryszko, Tomasz
    Szablak-Uliszewska, Emilia
    Naumnik, Beata
    [J]. POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2017, 71 : 1198 - 1206
  • [3] Is serum sclerostin a marker of atherosclerosis in patients with chronic kidney disease–mineral and bone disorder?
    Andreja Figurek
    Goce Spasovski
    [J]. International Urology and Nephrology, 2018, 50 : 1863 - 1870
  • [4] Sclerostin and chronic kidney disease: the assay impacts what we (thought to) know
    Delanaye, Pierre
    Paquot, Francois
    Bouquegneau, Antoine
    Blocki, Frank
    Krzesinski, Jean-Marie
    Evenepoel, Pieter
    Pottel, Hans
    Cavalier, Etienne
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 (08) : 1404 - 1410
  • [5] Is serum sclerostin a marker of atherosclerosis in patients with chronic kidney disease-mineral and bone disorder?
    Figurek, Andreja
    Spasovski, Goce
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2018, 50 (10) : 1863 - 1870
  • [6] Sclerostin within the chronic kidney disease spectrum
    Bouquegneau, Antoine
    Evenepoel, Peter
    Paquot, Francois
    Malaise, Olivier
    Cavalier, Etienne
    Delanaye, Pierre
    [J]. CLINICA CHIMICA ACTA, 2020, 502 : 84 - 90
  • [7] CHRONIC KIDNEY DISEASE Chronic kidney disease and the ageing population
    Tonelli, Marcello
    Riella, Miguel C.
    [J]. NATURE REVIEWS NEPHROLOGY, 2014, 10 (03) : 127 - 128
  • [8] The relationship between sclerostin and carotid artery atherosclerosis in patients with stage 3–5 chronic kidney disease
    Ban Zhao
    Aiqun Chen
    Haitao Wang
    Ju Cui
    Ying Sun
    Lengnan Xu
    Yonghui Mao
    [J]. International Urology and Nephrology, 2020, 52 : 1329 - 1336
  • [9] Uremic toxicity and sclerostin in chronic kidney disease patients
    Desjardins, Lucie
    Liabeuf, Sophie
    Oliveira, Rodriguo B.
    Louvet, Loic
    Kamel, Said
    Lemke, Horst-Dieter
    Vanholder, Raymond
    Choukroun, Gabriel
    Massy, Ziad A.
    [J]. NEPHROLOGIE & THERAPEUTIQUE, 2014, 10 (06): : 463 - 470
  • [10] Chronic kidney disease and premature ageing
    Kooman, Jeroen P.
    Kotanko, Peter
    Schols, Annemie M. W. J.
    Shiels, Paul G.
    Stenvinkel, Peter
    [J]. NATURE REVIEWS NEPHROLOGY, 2014, 10 (12) : 732 - 742
12345